Undergraduate education

University of Michigan, BS, 2005

Years in MSTP



Molecular and cellular pharmacology, 2012


Ron Raines, PhD

Thesis title

Characterization and Exploitation of the Glycocalyx for Drug Delivery


Pathology, Harvard University, Medical School, 2014-2017


Broad Institute of MIT and Harvard, Center for the Science of Therapeutics, 2017-2018

Current position

Principal Scientist, Multiple Sclerosis Research Unit. Biogen. Cambridge, MA

PhD publications

Caes BR, Palte MJ, Raines RT. Organocatalytic conversion of cellulose into a platform chemical. Chemical Science. 2013 April; 4(1):196-199. PMID: 24596655; PMCID: PMC3939028.

Palte MJ, Davis AK, McGrath NA, Spiegel CA, Raines RT. Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug. ChemMedChem. 2012 Aug;7(8):1361-4. PMID: 22807330; PMCID: PMC3516917.

Palte MJ, Raines RT. Interaction of nucleic acids with the glycocalyx. J Am Chem Soc. 2012 Apr 11;134(14):6218-23. PMID: 22400897; PMCID: PMC3353769.

Lukesh JC 3rd, Palte MJ, Raines RT. A potent, versatile disulfide-reducing agent from aspartic acid. J Am Chem Soc. 2012 Mar 7;134(9):4057-9. PMID: 22353145; PMCID: PMC3353773. As featured in Chemical & Engineering News: A better disulfide reducing agent. 2012 Feb 29.

Ellis GA*, Palte MJ*, Raines RT. Boronate-mediated biologic delivery. J Am Chem Soc. 2012 Feb 29;134(8):3631-4: 22303837; PMCID: PMC3304437. (* Denotes equal contribution.) As featured in Nature, 484, 9(2012): Community Choice Highlight, Proteins’ ticket into the cell. As featured in Chemical & Engineering News: Drug Delivery Hooked on Sugar. 2012 Feb 15.

Ellis GA, McGrath NA, Palte MJ, Raines RT. Ribonuclease-Activated Cancer Prodrug. ACS Med Chem Lett. 2012 Feb 28;3(4):268-272. PMID: 22611478; PMCID: PMC3353771.